Table 3.
Clinical measures for individuals with and without sudden gains (n = 63)
| Pre-treatment | Post-treatment | Follow-up 1 (M=3.4 months) |
Follow-up 2 (M=12.1 months) |
|
|---|---|---|---|---|
| Total sample (N=63) | ||||
| CPSS | 24.8 (9.4) | 7.1 (7.3) | 5.5 (6.8) | 5.4 (6.4) |
| Converted BDIa | 15.3 (8.6) | 6.8 (7.3) | 5.3 (6.5) | 5.6 (7.1) |
| Individuals with sudden gains (N=31) |
||||
| CPSS | 25.7 (9.0) | 3.9 (4.0) | 2.5 (3.0) | 3.5 (4.3) |
| Converted BDIa | 15.9 (8.3) | 4.3 (5.2) | 3.4 (4.9) | 4.4 (6.0) |
| Individuals without sudden gains (N=32) |
||||
| CPSS | 23.9 (9.7) | 10.2 (8.4) | 8.4 (8.0) | 7.2 (7.6) |
| Converted BDIa | 14.8 (9.0) | 9.2 (8.2) | 7.2 (7.4) | 6.8 (7.9) |
Note. The last-observation-carried-forward (LOCF) technique was used to impute missing values in follow-up measurements; CPSS = Child posttraumatic stress disorder symptom scale; BDI = Beck depression inventory.
a
To facilitate comparison we converted CDI scores into BDI scores. First, we divided CDI scores by the total possible score (54) and turned them into percentages. Second, we multiplied these percentages by the total BDI score (63) to assign a converted BDI score.